Gut Microbiota in Health and Disease

被引:2929
作者
Sekirov, Inna
Russell, Shannon L.
Antunes, L. Caetano M.
Finlay, B. Brett [1 ]
机构
[1] Univ British Columbia, Michael Smith Labs, Dept Microbiol & Immunol, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada
关键词
SEGMENTED FILAMENTOUS BACTERIA; IRRITABLE-BOWEL-SYNDROME; TREATMENT PARTIALLY PROTECTS; RUMINOCOCCUS-GNAVUS STRAIN; INTESTINAL DENDRITIC CELLS; CONJUGATED LINOLEIC-ACID; NITRIC-OXIDE SYNTHASE; DIET-INDUCED OBESITY; DIABETES-PRONE RAT; GERM-FREE MICE;
D O I
10.1152/physrev.00045.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Gut microbiota is an assortment of microorganisms inhabiting the length and width of the mammalian gastrointestinal tract. The composition of this microbial community is host specific, evolving throughout an individual's lifetime and susceptible to both exogenous and endogenous modifications. Recent renewed interest in the structure and function of this "organ" has illuminated its central position in health and disease. The microbiota is intimately involved in numerous aspects of normal host physiology, from nutritional status to behavior and stress response. Additionally, they can be a central or a contributing cause of many diseases, affecting both near and far organ systems. The overall balance in the composition of the gut microbial community, as well as the presence or absence of key species capable of effecting specific responses, is important in ensuring homeostasis or lack thereof at the intestinal mucosa and beyond. The mechanisms through which microbiota exerts its beneficial or detrimental influences remain largely undefined, but include elaboration of signaling molecules and recognition of bacterial epitopes by both intestinal epithelial and mucosal immune cells. The advances in modeling and analysis of gut microbiota will further our knowledge of their role in health and disease, allowing customization of existing and future therapeutic and prophylactic modalities.
引用
收藏
页码:859 / 904
页数:46
相关论文
共 352 条
  • [1] Abeysuriya V, 2008, HEPATOB PANCREAT DIS, V7, P633
  • [2] Probiotics in prevention of IgE-associated eczema:: A double-blind, randomized, placebo-controlled trial
    Abrahamsson, Thomas R.
    Jakobsson, Ted
    Bottcher, Malin Fageras
    Fredrikson, Mats
    Jenmalm, Maria C.
    Bjorksten, Bengt
    Oldaeus, Goran
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (05) : 1174 - 1180
  • [3] Aggarwal BB, 2003, ANTICANCER RES, V23, P363
  • [4] Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane
    Alakomi, HL
    Skyttä, E
    Saarela, M
    Mattila-Sandholm, T
    Latva-Kala, K
    Helander, IM
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (05) : 2001 - 2005
  • [5] DIFFERENTIAL CELL-KINETICS IN THE ILEUM AND COLON OF GERM-FREE RATS
    ALAM, M
    MIDTVEDT, T
    URIBE, A
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (05) : 445 - 451
  • [6] Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice
    Alpert, Carl
    Scheel, Jacqueline
    Engst, Wolfram
    Loh, Gunnar
    Blaut, Michael
    [J]. ENVIRONMENTAL MICROBIOLOGY, 2009, 11 (04) : 751 - 761
  • [7] Commensal microbiota is fundamental for the development of inflammatory pain
    Amaral, F. A.
    Sachs, D.
    Costa, V. V.
    Fagundes, C. T.
    Cisalpino, D.
    Cunha, T. M.
    Ferreira, S. H.
    Cunha, F. Q.
    Silva, T. A.
    Nicoli, J. R.
    Vieira, L. Q.
    Souza, D. G.
    Teixeira, M. M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (06) : 2193 - 2197
  • [8] [Anonymous], 2006, C SER
  • [9] [Anonymous], 2003, COCHRANE DB SYST REV
  • [10] Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
    Antonopoulos, Dionysios A.
    Huse, Susan M.
    Morrison, Hilary G.
    Schmidt, Thomas M.
    Sogin, Mitchell L.
    Young, Vincent B.
    [J]. INFECTION AND IMMUNITY, 2009, 77 (06) : 2367 - 2375